Diligence memo · auto-generated · as of July 3, 2026

Caire Health Holdings, Inc.

Caire Health Holdings, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Caire Health Holdings, Inc. operates in Medical Devices, based in NEW YORK, USA. Semi-Autonomous Diagnostics for Emergent Care

Sub-sector tags: Artificial Intelligence, Medical Devices, ai/ml, medical-devices.

Capital & rounds (filed)filed

Caire Health Holdings, Inc. has raised $6.7M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.7M on 2023-01-30.

Most recent recorded round closed around 2023-01-30.

Valuation (modeled)modeled

Provath models Caire Health Holdings, Inc. at approximately $58M (range $8.2M–$174M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.00× the median modeled value of Series A Medical Devices companies in 2022–2024 (13 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 3.4 yr ago; this sector typically re-raises about every 16 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 73% of Medical Devices peers (233 compared).

Modeled value ranks above 79% of those peers.

Closest niche peers: MBio Diagnostics, Inc., Vida Diagnostics Inc, New View Surgical, Inc., Thunder Road Surgical, Llc, Barsa Surgical Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.